| CASE REPORT |
|
| Year : 2023 | Volume
: 3
| Issue : 2 | Page : 409-411 |
|
|
Intravitreal clindamycin-induced macular infarct in a case of ocular toxoplasmosis
Megha B Patel1, Amit S Nene1, Smitesh Shah1, Pratik Shenoy1, Pushpanjali Ramteke1, Sonali Padwal2, Onkar H Pirdankar2
1 Department of Ophthalmology, Isha Netralaya, Kalyan, Maharashtra, Isha Netralaya, Maharashtra, India
2 Department of Optometry, Isha Netralaya, Kalyan, Maharashtra, Isha Netralaya, Maharashtra, India
Correspondence Address:
Onkar H Pirdankar
Isha Netralaya, Radhakrishna Sankul, Opp. Holy Cross Hospital, Karnik Road, Kalyan - 421 301, Maharashtra
India
 Source of Support: None, Conflict of Interest: None
DOI: 10.4103/IJO.IJO_3075_22
|
|
|
Intravitreal clindamycin is one the modalities in managing ocular toxoplasmosis. Here we report clindamycin-induced macular infarct followed by full thickness macular hole with epiretinal membrane and macular atrophy. A 54-year-old male diagnosed with ocular toxoplasmosis in the right eye was treated with intravitreal injection of clindamycin and dexamethasone. Patient developed macular infarction with epiretinal membrane (ERM) and full thickness hole, with corresponding decrease in visual acuity and was managed with vitrectomy. Clindamycin injection has potential to cause retinal complications, and hence, one needs to be extremely cautious while preparing the proper concentration of clindamycin as it requires appropriate dilution.
|
|
|
|
| [FULL TEXT] [PDF]* |
|
 |
|
